By: Eric Blancaro
CVS Health is making headlines this week as its shares experienced a notable uptick, rising 2.8% in premarket trading on Monday. This surge follows a report from the Wall Street Journal detailing CVS's strategic move to expand its board of directors, a decision stemming from an agreement with Glenview Capital Management. This hedge fund has been vocal about the need for changes within CVS, and the addition of four new board members signals a significant shift in the company's governance.